Clinical TrialsSearch results
Number of results: 821
Recruiting
- PSMA-DC: An Open-label study comparing lutetium (177Lu) vipivotide tetraxetan (also known as [177Lu]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617) versus observation in PSMA positive OMPC (CAAA617D12302).
- Oligometastatic Prostate Cancer (OMPC) by PSMA PET, M1 negative by CI.
- Yamauchi Kyosuke
- 2024-01-31
Not yet recruiting
- A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Plaque psoriasis
- Nakano Masayoshi
- 2024-01-26
Recruiting
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
- Plaque Psoriasis
- Shikamura Mitsuhiro
- 2024-01-22
Recruiting
- A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Ulcerative Colitis
- Kawai Norisuke
- 2024-01-22
Recruiting
- Effects of Sodium Zirconium Cyclosilicate on Quality Of Life in patients with hyperkalemia undergoing hemodialysis
- Chronic kidney disease
- Wakui Hiromichi
- 2024-01-15
Recruiting
- The Vasopressin Loading for Refractory septic shock (VALOR) study
- septic shock
- Nakamura Kensuke
- 2024-01-15
Other
- A study to test whether BI 685509 helps people with liver cirrhosis and high blood pressure in the portal vein (main vessel going to the liver) who had bleeding in the esophagus or fluid accumulation in the belly
- CSPH in decompensated liver cirrhosis regardless of the etiology of chronic liver disease
- Taguchi Aya
- 2024-01-12
Recruiting
- Phase 3 Program to Evaluate MK-7240 for Moderate to Severe Ulcerative Colitis
- Ulcerative Colitis
- Tanaka Yoshiyuki
- 2024-01-12
Completed
- Effect of mouthwash on the reduction of salivary SARS-CoV-2
- COVID-19
- Kutsuna Satoshi
- 2024-01-12
Not yet recruiting
- An investigation for the efficacy of tuna dark muscle ingestion on physical performance, fatigue level, and on clinical data in male long distance runner
- Fatigue recovery power
- Nishizaki Yasuhiro
- 2024-01-10